World of DTC Marketing
DECEMBER 29, 2021
The demand quickly exceeded supply after the FDA approved once-weekly semaglutide injections. Semaglutide’s study results were enough to warrant plenty of hype for obesity treatment. The drug got a PR boost from Marc Andreessen, who called semaglutide a “silver bullet” and “miracle drug” for suppressing appetite. Unfortunately, the hype is going to exceed reality.
Dinamic OR
DECEMBER 29, 2021
Hundreds of hospitals across the United States have temporarily postponed elective surgeries in deference to the fact that COVID-19 patients are occupying more beds in their facilities, and there simply isn’t room enough to accommodate patients requiring less urgent procedures. It’s also true that short-staffed healthcare facilities are overworked, and many staff are nearing the point of burnout.
Expert insights. Personalized for you.
191 
Let's personalize your content